PicoSeq announced today that it is changing its corporate name to Depixus. “The name change reflects the company’s breadth of interest across both genetic and epigenetic analysis, with our technology being developed for applications far beyond just DNA sequencing” said Gordon Hamilton, Depixus’ Président (CEO).

The new name is effective immediately and will be implemented across the company over the coming weeks.